parasitic diseases in humans
parasitic diseases in humans FDA Approves Egaten for the Treatment of ‘Fluke Infestation’ - PrecisionVaccinations Posted: 16 Feb 2019 12:00 AM PST The US Food and Drug Administration (FDA) announced it has approved Egaten® (triclabendazole) for the treatment of fascioliasis, in patients 6 years of age and older. This FDA announcement is important since Egaten is now the only FDA-approved drug for people with fascioliasis. Fascioliasis, commonly known as liver fluke infestation, is a neglected tropical disease that infects 2.4 million people worldwide, with an additional 180 million at risk of infection, says the Centers for Disease Control and Prevention. It is caused by two species of parasitic flatworms that can infect humans following ingestion of larvae in contaminated water or food. Fascioliasis is recognized by the FDA as a neglected tropical disease, triggering the award of a Priority Review Voucher based upon t...